臨床試驗

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

NCT：NCT07523750 · RECRUITING

NCT IDNCT07523750

狀態RECRUITING

開始日期2026-04-02

完成時間2028-05-31

SponsorBiosense Webster, Inc. (INDUSTRY)

First posted2026-04-13

Last updated2026-09-15

簡要摘要

The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in participants with symptomatic persistent atrial fibrillation (PsAF; continuous irregular, rapid heartbeat that lasts over 7 days and doesn't stop on its own).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。